DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Atreya C, Van Cutsem E, Bendell JC. et al.
Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC).
J Clin Oncol 2016;
33: 2
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.